tbuckley/cabot-search huggingface dataset:
Efficacy and Safety in Patients with Lenalidomide-Refractory Multiple Myeloma after 1-3 Prior Lines Who Received a Single Infusion of Ciltacabtagene Autoleucel As Study Treatment in the Phase 3 CARTITUDE-4 Trial
Authors: M Hasib Sidiqi, Paolo Corradini, Duncan Purtill, Hermann Einsele, Binod Dhakal, Lionel Karlin, Salomon Manier, Shinsuke Iida, Sebastian Giebel, Simon J. Harrison, Brea Lipe, Abdullah Khan, Jordan M. Schecter, Carolyn Chang Jackson, Tzu-min Yeh, Arnob Banerjee, William Deraedt, Nikoletta Lendvai, Carolina Lonardi, Ana Slaughter, Katherine Li, Diana Chen, Jane Gilbert, Tito Roccia, Man Zhao, Nitin Patel, Erika Florendo, Mythili Koneru, Octavio Costa Filho, Dong Geng, Jesus San Miguel, Kwee Yong
Journal: Blood (2023)
Outcomes of Incorporating IV Daratumumab for the Treatment of AL Amyloidosis in Real World Patients from a Multicenter Registry in Latin America
Authors: Erika Barbara Brulc, Natalia Paola Schutz, Maria Lourdes Posadas, Elsa Mercedes Nucifora, Maria Adela Aguirre, Guillermina Remaggi, Patricio Duarte, Claudia Shanley, Maria Elvira Giannini
Journal: Blood (2023)
Small-Dose Trimethoprim-Sulfamethoxazole Prevents Pneumocystis Jiroveci Pneumonia in B-Cell Lymphoma Patients Receiving Chemotherapy: Analysis of a Randomized Controlled Clinical Trial
Authors: Chunxiao Liu, Xuewu Zhang, Yanan Zhu, Feng Xiao, Yunfei Lv, Xingnong Ye, Xia Li, Juying Wei, Huafeng Wang, Yile Zhou, Hongyan Tong, Xinping Zhou, Chunmei Yang, Liping Mao, De Zhou, Li Zhu, Xiaolong Zheng, Li Ye, Liangshun You, Jie Jin, Wenjuan Yu
Journal: Blood (2023)
Updated Results of the Phase I BALLI-01 Trial of UCART22 Process 2 (P2), an Anti-CD22 Allogeneic CAR-T Cell Product Manufactured By Cellectis Biologics, in Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Authors: Nitin Jain, Patrice Chevallier, Hongtao Liu, Gary J. Schiller, Jean-Baptiste Méar, Daniel J. DeAngelo, Kevin J Curran, Stephan Grupp, Andre Baruchel, Marie Balsat, Alexandra LaCroce, Caroline Roudet, Ana B. Korngold, Kathryn J. Newhall, Eric Laille, Daniel J. Lee, Mark G. Frattini, Richard A. Larson, Nicolas Boissel
Journal: Blood (2023)
Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study
Authors: Tami D. John, Deepak Chellapandian, Rikin Shah, Scott Gillespie, Katie Liu, Yijin Xiang, Monica Bhatia, Sonali Chaudhury, Michael J. Eckrich, Gregory M.T. Guilcher, Jennifer Jaroscak, Kimberly A. Kasow, Jennifer Krajewski, Alexander I. Ngwube, Timothy S Olson, Hemalatha G. Rangarajan, John T. Horan, Lakshmanan Krishnamurti, Shalini Shenoy, Allistair Abraham, Elizabeth Stenger
Journal: Blood (2023)
Cladribine and Cyclophosphamide Lymphodepletion Prior to Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma
Authors: Filip Ionescu, Bijal D. Shah, Meghan Menges, Kayla Reid, Hanna Bailey, Elizabeth DiMaggio, Rebecca Gonzalez, Christina A Bachmeier, Salvatore Corallo, Luis Cuadrado Delgado, Turab Mohammed, Taiga Nishihori, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Marco Davila, Fabiana Perna, Julio C Chavez, Frederick L. Locke, Michael D. Jain
Journal: Blood (2023)
Systemic Amyloid Response in Patients with AL Amyloidosis Assessed By Serial Iodine ( 124I) Evuzamitide PET/CT Imaging
Authors: Emily B Martin, Alan Stuckey, Bryan Whittle, Dustin Powell, R. Eric Heidel, Renju Raj, Anne Kassira, Stephen J. Kennel, Spencer Guthrie, Jonathan S. Wall
Journal: Blood (2023)
<i>Calr</i> Variant Allele Frequency in Essential Thrombocythemia: Molecular Associations and Impact on Disease Phenotype and Outcome
Authors: Paola Guglielmelli, Natasha Szuber, Naseema Gangat, Giulio Capecchi, Chiara Maccari, Lambert Busque, Omer Karrar, Maymona Abdelmagid, Manjola Balliu, Alessandro Atanasio, Ilaria Sestini, Audrey Desilets, Giuseppe Gaetano Loscocco, Giada Rotunno, Marie-Christine Meunier, Michael Harnois, Ayalew Tefferi, Alessandro Maria Vannucchi
Journal: Blood (2023)
Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
Authors: John L. Reagan, Rabin Niroula, Jessica McMahon, Pamela Egan, Inna Yakirevich, Mandy Pereira, Ari Pelcovits, Jeannine Margolis, Ashlee Sturtevant, Peter J. Quesenberry, Loren D. Fast
Journal: Blood (2023)
Isatuximab-Based Regimens As Salvage Therapy for Patients with Multiple Myeloma: Sardinian, Multicenter, Retrospective Clinical Practice Experience with 27 Cases Outside of Controlled Clinical Trials
Authors: Daniele Derudas, Luigi Podda, Angelo D. Palmas, Rita Floris, Annamaria Liguori, Cristina Depau, Alessandro Bianchi, Claudio Fozza, Giorgio La Nasa
Journal: Blood (2023)
The Impact of Inotuzumab Ozogamicin (InO) Treatment on Brexucabtagene Autoleucel (Brexu-cel) Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Authors: Ibrahim Aldoss, Gregory W Roloff, Anjali S. Advani, Noam E. Kopmar, Chenyu Lin, Simone E. Dekker, Vishal K Gupta, Nikeshan Jeyakumar, Timothy E O'Connor, Amy Zhang, Katharine Miller, Kaitlyn C Dykes, Mohamed Ahmed, Hector Zambrano, Danielle Bradshaw, Santiago Mercadal, Marc Schwartz, Sean Tracy, Bhagirathbhai Dholaria, Michal Kubiak, Akash Mukherjee, Navneet Majhail, Minoo Battiwalla, Luke Mountjoy, Shahbaz A. Malik, John Mathews, Paul Shaughnessy, Aaron C. Logan, Abdullah Ladha, George Yaghmour, Maryann Stefan, Caitlin Guzowski, Rasmus T. Hoeg, Talal Hilal, Jozal Moore, Kristen M. O'Dwyer, Stephanie B. Tsai, Joshua Sasine, Melhem M. Solh, Catherine J. Lee, Vamsi K. Kota, Divya Koura, Muthu Veeraputhiran, Betsy Blunk, Jessica T. Leonard, Caspian H. Oliai, Veronika Bachanova, Wendy Stock, Ahmed Galal, Vinod Pullarkat, Ryan D Cassaday, Bijal D. Shah, Rawan Faramand, Lori S. Muffly
Journal: Blood (2023)
Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in a Diverse Patient Population with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius
Authors: Michael Rosenzweig, Yvonne Efebera, Efstathios Kastritis, Brandon Blue, Faizi Jamal, Monique C Minnema, Christopher Pericone, Sandra Vasey, Yuping Chen, Sonja Kotoulek, Bart Vandael, Joana Duran, Samer Khaled, NamPhuong Tran, Jessica Vermeulen, Vaishali Sanchorawala
Journal: Blood (2023)
Belantamab Mafodotin in Relapse/Refractory AL Amyloidosis- Real-Life Multi-Center Experience
Authors: Eyal Lebel, Vladimir Vainstein, Paolo Milani, Giovanni Palladini, Tamir Shragai, Noa Lavi, Hila Magen, Assayag Miri, Irit Avivi Mazza, Moshe E Gatt
Journal: Blood (2023)
Impact of Front-Line Treatment Interim PET/CT in Peripheral T-Cell Lymphoma Patients' Survival: Experience of a Single Center
Authors: Nicolo Rampi, Montserrat Cortes-Romera, Patricia Lopez-Pereira, Carolina Martinez-Ramos, Clara Montane Carbo, Carolina Esther Arevalo Leon, Ana C. De Oliveira, Eva Maria Gonzalez Barca, Anna Maria Sureda Balari, Eva Domingo Domenech
Journal: Blood (2023)
A Genomic Approach for High-Grade B Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and / or <i>BCL6</i> Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results
Authors: Yann Guillermin, Pierre Sesques, Claire Mauduit, Arsène Vacherot, Marie-Charlotte Laude, Anne-Sophie Michallet, Catherine Chassagne, Alexandra Traverse-Glehen, Emmanuel Beillard
Journal: Blood (2023)
ONO-7018, a First-in-Class MALT1 Inhibitor, Provides Novel Therapeutic Strategies for B Cell Malignancies: Overcoming BTK Inhibitor Acquired Resistance and Enhancing the Antitumor Effect of BTK Inhibitors
Authors: Ryu Fujikawa, Yuka Komichi, Kazuya Ono, Tomoko Yasuhiro, Sergio Prados, Takao Yoshida, Ryohei Kozaki
Journal: Blood (2023)
Multiplex Prime Editing and PASSIGE TM for Non-Viral Generation of an Allogeneic CAR-T Cell Product
Authors: Emily J Pomeroy, Andrew V Anzalone, Christopher J Podracky, Noah B Bloch, Reyna Chang, Arika A Dwivedi, Kanut Laoharawee, Alan J Wilhelm, David P Waterman, Justin G Tedeschi, Upasana Sunil Arvindam, Elizabeth R Macari, Jennifer L Gori, Jeremy S Duffield
Journal: Blood (2023)
Efficacy and Safety of Polatuzumab Vedotin in Follicular Lymphoma: A Systematic Review of Clinical Trials
Authors: Samer Jumean, Wajeeha Aiman, Murad Qirem, Osama Alkhlaifat, Muhammad Ashar Ali, Hamid Shaaban, Gunwant Guron, Bader Al Omour, Amr Ramahi, Nooredeen Isbeih
Journal: Blood (2023)
Financial Trends of AML Patients over the Past Decade
Authors: Mark Dalgetty, Mahran Shoukier, Danielle Bradshaw, Faizan Boghani, Sruthi Athota, Anvay Shah, Meaghan Standridge, Michael Stokes, Mohammad Mian, Ayushi Chauhan, Amany R. Keruakous, Locke Johnson Bryan, Jorge Cortes, Anand Jillella, Vamsi K. Kota
Journal: Blood (2023)
Results from Multisite Implementation of Electronic Health Record Tools for Clinical Pre-Test Probability of Pulmonary Embolism in the Emergency Department
Authors: Damon E. Houghton, Lisa Baumann Kreuziger, Megan Keenan, Hayley Dykhoff, Kyle Campbell, Marie Hall, Heather Heaton, Kristine Thompson, Jaime Aranda, Sarah Balgord, Jonathan Rubin, Ali Raja, Sayon Dutta, Ryan Hanson, Dustin McEvoy, Wei He, Emily Cahill, Rachel P. Rosovsky
Journal: Blood (2023)
<i>Picalm::MLLT10</i> can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response
Authors: Haimin Sun, Yongmei Zhu, Jianfeng Li, Lingling Zhao, Guang Yang, Zeying Yan, Ying Wang, Zhiyin Liu, Ran An, Sujiang Zhang
Journal: Blood (2023)
A CX3CR1 (fractalkine receptor) Small Molecular Antagonist (KAND567) Suppressed the Growth Promoting Effect of Monocytes on Chronic Lymphocytic Leukemia Cells
Authors: Mohammad Hojjat-Farsangi, Wen Zhong, Tom Mulder, Ann Svensson, Jeanette Lundin, Marzia Palma, Johan Schultz, Thomas Olin, Bjorn Wahlin, Anders Osterborg, Parviz Kokhaei, Hakan Mellstedt
Journal: Blood (2023)
Potent and Target Specific Cytotoxicity of PRAME TCR Mimic CAR T Cells in KMT2A-Rearranged AML Patient-Derived Xenograft Model
Authors: Danielle C Kirkey, Leila Robinson, Tiffany Hylkema, Anisha Loeb, Rhonda E Ries, Cyd McKay, Christina Root, Laura Pardo, Keith R. Loeb, Quy Le, David A. Scheinberg, Soheil Meshinchi
Journal: Blood (2023)
Real-World Clinical Outcomes in Patients with Relapse and Refractory Multiple Myeloma Received VTD-PACE Treatment in the Era of Monoclonal Antibody
Authors: Moe Yogo, Taku Kikuchi, Nobuhiro Tsukada, Kodai Kunisada, Yuki Okda, Kota Sato, Mizuki Ogura, Tomomi Takei, Yu ABE, Kenshi Suzuki, Tadao Ishida
Journal: Blood (2023)
Establishment of the Bcwm.2 Cell Line As a BTK-Inhibitor Resistant, BCL2 Inhibitor Sensitive <i>in Vitro</i> and <i>In Vivo</i> Study Model for Waldenström's Macroglobulinemia
Authors: Shirong Liu, Xia Liu, Kara M Soroko, Alexa G Canning, Amanda Kofides, Choudhury Fabliha Binte Yusuf, Johany Penailillo, Nickolas Tsakmaklis, Christopher J Patterson, Ruben D. Carrasco, Zachary R Hunter, Prafulla C. Gokhale, Shayna R Sarosiek, Jorge J. Castillo, Steven P Treon
Journal: Blood (2023)
“Defining the Optimal Post-CART Monitoring Period in Recipients of Axicabtagene Ciloleucel and Tisagenlecleucel”
Authors: William Wesson, Forat Lutfi, David L. Porter, Veronika Bachanova, Loretta J. Nastoupil, Peter A. Riedell, Miguel-Angel Perales, Richard T Maziarz, Jamie Brower, Gunjan L. Shah, Andy Chen, Olalekan O. Oluwole, Stephen J Schuster, Michael R. Bishop, Joseph P McGuirk, Nausheen Ahmed
Journal: Blood (2023)
Estimates of Survival and Life Expectancy with Tafasitamab Plus Lenalidomide in the L-Mind Study Compared with Real-World Standard-of-Care for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: Johannes Duell, Martin Dreyling, Gianluca Gaidano, Nagesh Kalakonda, Eva Maria Gonzalez Barca, Anna Marina Liberati, Zsolt Nagy, Daniel Moik, Mirko Vukcevic, Aasim Amin, Abhishek Bakuli
Journal: Blood (2023)
The Signaling Pathways Enriched in High-Risk AML Patients Revealed By the Integrative miRNA-mRNA Analysis - Pilot Study
Authors: Magdalena Czemerska, Damian Mikulski, Aneta Wisnik, Dariusz Jarych, Izabela Zawlik, Piotr Strzalka, Kinga Krawiec, Wojciech Fendler, Agnieszka Pluta, Agnieszka Wierzbowska
Journal: Blood (2023)
Presence of Recurrent Somatic Mutations in Mesenchymal Stromal Cell Fractions Isolated from Acute Myeloid Leukemia As an Evidence of Clonality
Authors: Muzaffar Bhatti, Taehyung Kim, Jenny Warrington, Amirthagowri Ambalavanan, Sarah Zarabi, Anthea Travas, Jaeyoon John Kim, Danielle Pyne, Troy Ketela, Andrea Arruda, Mark D. Minden, Armand Keating, Dennis Dong Hwan Kim
Journal: Blood (2023)
Incidence of Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study
Authors: Izel Okcu, Jihao Zhou, Yucai Wang, Thomas M. Habermann, Thomas E. Witzig, Gita Thanarajasingam, Patrick B Johnston, Lisa M. Rimsza, Allison M. Bock, Firas Baidoun, Muhamad Alhaj Moustafa, Grzegorz S. Nowakowski
Journal: Blood (2023)
Evaluation of Innovative Laboratory Tests to Predict a Thrombotic Phenotype in a Family with Dysfibrinogenemia and a Novel <i>FGG</i> Mutation
Authors: Amaury Monard, Floor Moenen, Elisabetta Castoldi, Ilaria De Simone, Paola Van Der Meijden, Kanin Wichapong, William van Doorn, Stefano Spada, Dave Hellenbrand, Alexander Stork, Hugo Ten Cate, Erik AM Beckers, Yvonne Henskens
Journal: Blood (2023)
Novel Combinatorial Therapeutic Options in NEAT1-Depleted Multiple Myeloma Cells By the Integration of in Vitro and in silico Drug Screening Approaches
Authors: Noemi Puccio, Elisa Taiana, Gloria Manzotti, Elisabetta Mereu, Domenica Ronchetti, Cecilia Bandini, Ilaria Craparotta, Laura Di Rito, Marco Bolis, Veronica Manicardi, Valentina Fragliasso, Nicola Amodio, Niccolò Bolli, Stefano Luminari, Alessia Ciarrocchi, Roberto Piva, Antonino Neri
Journal: Blood (2023)
Antigen-Specific T-Cell Repertoire Responses Following COVID-19 Vaccination Are Intact in Majority of Patients with B-Cell Lymphoid Malignancies on Active Therapy
Authors: Shipra Goel, Elizabeth A. Griffiths, Brahm Segal, Michael Nemeth, Matthew J Cortese, Francisco J. Hernandez-Ilizaliturri, Barbara Banbury, Erika Schumacher, Pallawi Torka, Paola Ghione
Journal: Blood (2023)
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Authors: Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, Guillermo Villacampa, Munetaka Takekuma, Ugo De Giorgi, Kristina Lindemann, Linn Woelber, Nicoletta Colombo, Linda Duska, Alexandra Leary, Ana Godoy-Ortiz, Shin Nishio, Antoine Angelergues, Maria Jesús Rubio, Lorena Fariñas-Madrid, Satoshi Yamaguchi, Domenica Lorusso, Isabelle Ray-Coquard, Luis Manso, Florence Joly, Jesús Alarcón, Philippe Follana, Ignacio Romero, Coriolan Lebreton, J Alejandro Pérez-Fidalgo, Mayu Yunokawa, Hanna Dahlstrand, Véronique D'Hondt, Leslie M Randall, Sophie Abadie-Lacourtoisie, Claudia Andreetta, Nerea Anzizar, Daiseuke Aoki, Maria-Pilar Barretina-Ginesta, Marco Battista, Charlotte Bellier, Anne Gry Bentzen, Dominique Berton, Bertrand Billemont, Line Bjørge, Maria Bjurberg, Destin Black, Alessandra Bologna, Elena Ioana Braicu, Claudia Casanova, Radoslav Chekerov, Annick Chevalier, Juan Fernando Cueva, Bastian Czogalla, Nicolas Delanoy, Dominik Denschlag, Oscar Derke, Michael Eichbaum, Takayuki Enomoto, Carmen Esteban, Michel Fabbro, Tanja Fehm, Annamaria Ferrero, Markus Fleisch, Anne Floquet, Antonio Frassoldati, Lydia Gaba, Angiolo Gadducci, Yolanda García, Elena Geuna, Eva Guerra, Lars Hanker, Anne-Claire Hardy-Bessard, Philipp Harter, Kosei Hasegawa, Kristina Hellman, Ana Herrero, Felix Hilpert, Dionyssios Katsaros, Matthias Koegel, Anthoula Koliadi, Jean-Emmanuel Kurtz, Bjoern Lampe, Andrea Alberto Lissoni, Alain Lortholary, Giorgia Mangili, Laura Mansi, Frederik Marmé, Cara Mathews, William Mina, Shinichiro Minobe, Katherine Moxley, Shoji Nagao, Ornella Nicoletto, Koji Nishino, Hiroshi Nishio, Shin Nishio, Ana Oaknin, Michaela Onstad, Beatriz Pardo, J Alejandro Pérez-Fidalgo, Carmela Pisano, Andrés Poveda, Julia Radosa, Leslie M. Randall, Isabelle Ray-Coquard, Andrés Redondo, Debra Richardson, Ignacio Romero, Graziana Ronzino, Maria Jesús Rubio, Frederic Selle, Munetaka Takekuma, Nobuhiro Takeshima, Giulia Tasca, Krishnansu Tewari, Yukiharu Todo, Giorgio Valabrega, Pauline Wimberger, Linn Woelber, Satoshi Yamaguchi, Benoît You, Mayu Yunokawa
Journal: The Lancet (2023)
Patient-Reported Outcomes (PRO) of Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent (ESA)-Naïve, Transfusion-Dependent (TD), Lower-Risk Myelodysplastic Syndromes (LR-MDS): Results from the Phase 3 COMMANDS Study
Authors: Esther Natalie Oliva, Uwe Platzbecker, Matteo Giovanni Della Porta, Guillermo Garcia-Manero, Valeria Santini, Pierre Fenaux, Jake Shortt, Rami S. Komrokji, Christopher Pelligra, Shien Guo, Jennifer Lord-Bessen, Hong Xiao, Aylin Yucel, Dimana Miteva, Shelonitda Rose, Sandra Kreitz, Mikkael A. Sekeres, Amer M. Zeidan
Journal: Blood (2023)
Quantification of <i>JAK2</i> V167F in Patients with Myeloproliferative Neoplasms: Comparison of NGS and Digital PCR with Quantitative PCR
Authors: Ruth Stuckey, Guillermo Santana, Yanira Florido, Adrián Segura-Díaz, Maria Teresa Gómez-Casares, Cristina Bilbao-Sieyro
Journal: Blood (2023)
Comprehensive Geriatric Assessment in Diffuse Large B-Cell Lymphomas Patients Older Than 70 Years Old: Prospective Single-Center Experience
Authors: Nicolo Rampi, Maite Antonio, Eva Domingo Domenech, Patricia Lopez-Pereira, Ana C. De Oliveira, Carmen Aguilera, Anna Maria Sureda Balari, Eva Maria Gonzalez Barca
Journal: Blood (2023)
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
Authors: Uwe Platzbecker, Valeria Santini, Pierre Fenaux, Mikkael A Sekeres, Michael R Savona, Yazan F Madanat, Maria Díez-Campelo, David Valcárcel, Thomas Illmer, Anna Jonášová, Petra Bělohlávková, Laurie J Sherman, Tymara Berry, Souria Dougherty, Sheetal Shah, Qi Xia, Libo Sun, Ying Wan, Fei Huang, Annat Ikin, Shyamala Navada, Faye Feller, Rami S Komrokji, Amer M Zeidan
Journal: The Lancet (2023)
Impact of Time from Referral to Treatment on Outcomes and Cost of Therapy for Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma: An Intention to Treat Analysis
Authors: Vivek Patel, Katherine Baker, Danielle Fishman, Spencer Lessans, Trent Morris, Bhagirathbhai Dholaria, Reena Jayani, Adetola A. Kassim, Tae Kon Kim, David Morgan, Olalekan O. Oluwole, Bipin N. Savani, Salyka M. Sengsayadeth, Shakthi Bhaskar
Journal: Blood (2023)
Real-World Impact of Differences in the World Health Organization (WHO) Classification and International Consensus Classification (ICC) Systems on the Diagnosis of Non-Hodgkin Lymphoma: An Analysis from the LEO Cohort Study
Authors: Brooj Abro, Matthew J. Maurer, Thomas M. Habermann, Richard Burack, Jennifer R. Chapman-Fredricks, Jonathon B. Cohen, Jonathan W. Friedberg, Giorgio Inghirami, Brad S. Kahl, Melissa C. Larson, Brian K. Link, Izidore S. Lossos, Peter Martin, Timothy J. McDonnell, Loretta J. Nastoupil, Shaun M. Riska, Sergei Syrbu, Francisco Vega, Kiran R. Vij, Christopher R. Flowers, James R. Cerhan, David L Jaye, Andrew L. Feldman
Journal: Blood (2023)
ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in the Chronic Phase
Authors: Nobuko Hijiya, Shruti Kapoor, Matthias Hoch, Laurence Descamps, Vishal Dhamal, Ana Paula Torres Cardoso
Journal: Blood (2023)
Selinexor Combined Bortezomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma with Extramedullary Disease(EMD) or High-Risk Cytogenetics
Authors: Yuping Zhong, Xiaoxia Chu, Junqing Xu, Xiaoqian Liu, Chenglu Yuan, Xia Zhou, Hongying Wu, Yayun Wang, Shuyuan Yu, Hongyan Zhang, Jay Mei
Journal: Blood (2023)
Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell (CART) Therapy in Patients with Relapse-Refractory Multiple Myeloma with Extramedullary Disease
Authors: Danai Dima, James A Davis, Aliya Rashid, Mikhaila Rice, Shaun DeJarnette, Leyla Shune, Jack Khouri, Shahzad Raza, Joseph P McGuirk, Faiz Anwer, Nausheen Ahmed, Al-Ola Abdallah, Hamza Hashmi
Journal: Blood (2023)
Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis: Durable Responses and Evidence of Disease Modification
Authors: Harinder Gill, Lester Au, Garret Man Kit Leung, Dorothy Tsai, Rita Yim, Lynn Chin, Vivian Li, Paul Lee, Albert Chun Fung Sin, Hsin An Hou, Chih-Cheng Chen, Yok Lam Kwong
Journal: Blood (2023)
Impact of Daratumumab on Hematopoietic Stem Cell Mobilization with G-CSF and on-Demand Plerixafor in Newly-Diagnosed Multiple Myeloma Patients
Authors: Roberto Mina, Bruno Garibaldi, Giuseppe Bertuglia, Andrea Casson, Barbara Sarina, Francesca Gay, Silvio Mercadante, Jacopo Mariotti, Mattia D'Agostino, Daniela Taurino, Stefania Oliva, Alessandra Larocca, Daniele Mannina, Chiara De Philippis, Giulia Benevolo, Tiziana Francisci, Marco Lorenzi, Benedetto Bruno, Armando Santoro, Sara Bringhen, Stefania Bramanti
Journal: Blood (2023)
Ultrasensitive Detection of SALL4 Oncoproteins in Peripheral Blood and Bone Marrow Aspirate: Companion Diagnostics and Therapeutic Monitoring
Authors: Sanjana Shah, Jun Liu, Yasmeen Senussi, Arek Melkonian, James Nuhfer, Scott Lovitch, Neal Lindeman, Annette S. Kim, David R. Walt, Li Chai
Journal: Blood (2023)
IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem/Stromal Cell Death Via RIPK1-Independent Necroptosis
Authors: Xiang Ren, Meili Ge, Jiali Huo, Jinbo Huang, Min Wang, Yingqi Shao, Yingchang Mi, Yizhou Zheng
Journal: Blood (2023)
Differences in Overall Survival for Non-Western Immigrant Patients Compared to Danish-Born Patients with Diffuse Large B-Cell Lymphoma
Authors: Mikkel Runason Simonsen, Lasse Hjort Jakobsen, Marianne Tang Severinsen, Henrik Frederiksen, Carsten Utoft Niemann, Judit Mészáros Joergensen, Michael Roost Clausen, Jørn Starklint, Søren Paaske Johnsen, Tarec Christoffer El-galaly, Joachim Baech
Journal: Blood (2023)
The ELEMENT-MDS Trial: A Phase 3 Randomized Study Evaluating Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Non-Transfusion-Dependent, Lower-Risk Myelodysplastic Syndromes
Authors: Amer M. Zeidan, Rami S. Komrokji, Rena Buckstein, Valeria Santini, Shelonitda Rose, Priya Malini, Glen Lew, Dimple Aggarwal, Karen L. Keeperman, Huijing Jiang, Ana Carolina Giuseppi, Jennie Zhang, Thomas Cluzeau, Jake Shortt, Uwe Platzbecker
Journal: Blood (2023)
Clinical Features and Outcomes of Hemophagocytic Lymphohistiocytosis Secondary to Lymphoma: Insights from a Tertiary Center in Saudi Arabia
Authors: Rahaf ElHussein Salem, Mohamed H. Omer, Hind Salama, Ayman Alhejazi, Ayman Ibrahim, Sara Qubaiban, Abdulaziz Abdullah Alahmary, Maryam AlMutairi, Abdulrahman Al Raizah, Mohsen Alzahrani, Ahmed Alaskar
Journal: Blood (2023)
Persistent Contamination By Bone and Bone Marrow-Derived Macrophages Obscures Functional Assessment of Tissue-Dependent Heterogeneity in Mesenchymal Stromal Cells
Authors: Yuko Kawano, Hiroki Kawano, Stephanie Busch, Allison Li, Jane Zhang, Noah A Salama, Emily R Quarato, Chunmo Chen, Mary Georger, Mitra Azadniv, Daniel Byun, Elizabeth A Lamere, Mark W Lamere, Jane L. Liesveld, Michael W. Becker, Laura Calvi
Journal: Blood (2023)
ASC4START and ASC4FIRST: Two Ongoing Phase 3 Trials Investigating Asciminib Monotherapy As First-Line Therapy Versus Tyrosine Kinase Inhibitors in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Authors: Andreas Hochhaus, Jorge Cortes, Naoto Takahashi, Richard A. Larson, Ghayas C. Issa, Felice Bombaci, Susanne Saussele, Francois Mahon, Tim H. Brümmendorf, Shruti Kapoor, Tracey McCulloch, Peter Schuld, Timothy P Hughes
Journal: Blood (2023)